Technical

The Price Picture

After a brutal 2025 — peak-to-trough drawdown of roughly two-thirds following the July marketplace pre-announcement and Q3 goodwill impairment — Centene's chart has quietly turned. Price reclaimed the 200-day moving average in late January 2026 (golden cross 2026-01-30), the 1-month return is +28%, and MACD momentum has flipped decisively positive. The reading from price action is more constructive than the trailing GAAP loss in the Numbers tab would suggest: the market appears to be re-rating CNC out of distress and toward a normal-earnings reset, but the rally is now stretched (RSI 69) and bumping into clear resistance.

Snapshot

The trend — 10 years of price with 50/200-day moving averages

Price is above the 200-day, by 15.4% (close $41.82 vs SMA200 $36.25). The 10-year chart shows three regimes clearly: the 2016–2018 secular advance to a $148 all-time high, a multi-year sideways grind from 2019–2024 in the $50–$95 range, and the 2025 collapse to a fresh decade low of $25 in August. The current move is the first confirmed reclamation of trend after that collapse — an emerging uptrend, not yet a confirmed one.

Relative strength vs benchmark

Momentum — RSI and MACD over the last 18 months

RSI is at 69.3 — within a hair of the 70 overbought line and up from a deeply oversold 15 reading at the July 2025 panic low. MACD histogram has held positive and expanding for three consecutive weeks since flipping in early April, after a brief negative excursion in March. Near-term (1–3 month) momentum is unambiguously bullish, but RSI is now stretched enough that a near-term consolidation is the higher-probability path before the next leg up.

Volume and conviction

The 50-day average volume is now 5.95M shares/day, down from the post-shock peak of roughly 19M in August 2025 and back toward the pre-July baseline near 5M. The recent rally off the March low has been on lighter-than-average volume — conviction behind the bounce is moderate, not the kind of capitulatory turn that usually marks durable bottoms. The biggest volume days remain the July 2025 selloff cluster.

The top three volume-spike days all cluster around the early-July 2025 marketplace pre-announcement — the same event that drove the FY25 GAAP loss flagged in the Numbers tab. Price action and fundamentals tell the same story here, with no divergence to flag.

Volatility regime

The July 2025 single-day -40% move drove 30-day realized vol to a 10-year extreme above 150% — visible as the spike at the right of the chart. Today's reading of 38.0% sits in the upper-normal band (just below the p80 stressed line of 40.5%), meaningfully elevated vs the long-run median of 30% but no longer in crisis territory. The market is still pricing residual uncertainty about the 2026 medical loss ratio reset; vol has not normalized.

Technical scorecard and stance

Stance — cautiously bullish, 3-to-6 month horizon. The technical picture has flipped from outright bearish (death cross October 2024, 18-month downtrend, July capitulation) to early-stage recovery (golden cross January 2026, MACD turning, price above 200-day). What it has not done is fully confirm — relative strength is still negative, volume on the rally is unimpressive, and RSI 69 sits one short consolidation away from a pullback. The two levels that resolve the picture: a sustained close above $48 confirms a breakout above the post-shock $36–$45 trading range and validates the bullish case, while a break of $36 (the rising 200-day) restores the prior downtrend and re-opens the move toward the $25 panic low. Read alongside the Numbers tab — where the cash engine remained intact through the GAAP loss — the price chart is consistent with a market starting to look past the 2025 underwriting miss, but not yet betting on it.